DiaMedica Therapeutics (DMAC)
(Delayed Data from NSDQ)
$2.82 USD
-0.13 (-4.41%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $2.86 +0.04 (1.42%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth F Momentum F VGM
Brokerage Reports
DiaMedica Therapeutics, Inc. [DMAC]
Reports for Purchase
Showing records 1 - 19 ( 19 total )
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: DiaMedica Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare- Join our Call Today at 11AM to Unlock the Potential of DM199 in CKD and Stroke
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
|